Definition: An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself.
carbidopa, levodopa drug combination [ BMS brand of carbidopa, levodopa drug combination,Bristol-Myers Squibb brand of carbidopa, levodopa drug combination,Grifoparkin,Laboratorios Chile SA brand of carbidopa, levodopa drug combination,Nacom,Nakom,Parcopa,Schwarz Pharma brand of carbidopa, levodopa drug combination,Sinemet,Sinemet CR,Sinemet CR4,carbidopa - levodopa,tidomed ]